ce-spotlight

---------------------------------

The Pharmacist e-Link™ Continuing Education Center is designed to provide you with expanded online access to the highest quality of continuing education on a complimentary basis, through the convenience of the Velocity™ Online Learning Management System.

---------------------------------

---------------------------------

Need Help logging into the Pharmacicst e-Link site?
Click Here for Registration and
Login Information

---------------------------------

banner rdc


	This system allows you to search for relevant content from today’s leading providers in the world of continuing education, maintain your personal curriculum, bank your continuing education credits (both online and offline), track and print your professional transcript and more…

Pharmacist e-Link CE Spotlight

Challenges in Chronic Pain Management - An Update COX2s and Traditional NSAIDs: Risks and Benefits in Pain Management
There are anecdotal reports about the COX-2 inhibitors of improved efficacy over the traditional NSAIDs. This program will help the practitioner identify those patients with specific risk factors, in whom the risks would outweigh potential benefits, and properly educate those for whom COX-2 use is still an option.
This program is supported by an educational grant from Pfizer Inc.

Incretin Mimetics: The Why, When, and How in Treating Patients with Type 2 Diabetes
This program will review the physiological actions of the incretin hormones and discuss the use of incretin-related therapies in maintaining glycemic control in patients with type 2 diabetes.
This activity is funded through an educational grant from Amylin Pharmaceuticals, Inc., and Eli Lilly and Company.

Chronically Questioned About Chronic Constipation?
Chronic adult idiopathic constipation affects 55 million people in the United States, but because healthcare practitioners and patients often define the condition differently, there is a lack of diagnosis and proper treatment. Chronic adult idiopathic constipation can have deleterious effects on health and quality of life.
Supported by an educational grant from Takeda Pharmaceuticals North America Inc.

Other Featured CE

thumbnail

Opportunities and Guidelines for Aggressive Prevention of Secondary Stroke
This activity is designed to provide hospital pharmacists and managed markets physicians with education on the burden of primary and secondary stroke and the importance of early and aggressive stroke prevention in the hospital setting.
This activity is supported by an educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.

thumbnail

Counseling Patients on the Use of Pancreatic Exocrine Insuffiency (PEI) Drug Products: An Update
Pancreatic extract drug products are indicated in the treatment of exocrine pancreatic insufficiency, a potential complicating factor in cystic fibrosis, chronic pancreatitis, pancreatic tumors, or pancreatectomy. The safe and effective use of pancreatic enzyme drug products requires standardized enzyme activity and consistent drug therapy.
Commercial Support Provided by Solvay Pharmaceuticals, Inc.

thumbnail

Opportunities in Pharmacy: Adult Immunizations and the Vaccination Niche in the Community Pharmacy
The community pharmacy presents a conveniently accessible health care location for the provision of immunizations to the adult population of the community. This program will cover the basics needed to start an immunization niche and help you to formulate a plan for launching this professionally and financially rewarding niche.
Commercial Support Provided by Merck.

Please click here to forward this newsletter to a friend